By Rebecca Shohet Published November 2, 2015
With the recent rising prices of pharmaceutical drugs, Americans are demanding full transparency of these companies to understand how these exuberant prices for medications are decided on. Although various aspects of pharma companies' expenses have become public in the last few years, they are still weary to disclose sensitive information such as the amount of funding they get for research and trials as well as the method they use to set prices. Many Americans have started grass-roots movements to protest these price increases and both state and federal governments have opposed pharma companies by forcing them to disclose their finances. Two democratic candidates in the 2016 presidential election have also spoken vehemently about various approaches to lower these drug prices.
By Rebecca Shohet Published September 21, 2015
The shortage of primary care physicians is an issue that can prove immensely detrimental to the near future of our American healthcare system. As our population now lives longer, the number of sick people in the U.S will grow at a faster rate than the matriculation of new doctors into the health system. The Affordable Care Act also puts a strain on primary care doctors as they now have more patients to see. Numerous policy recommendations such as increasing responsibilities for nurses to lift the burden off physicians and improving technologies can be implemented to help solve the primary care physician shortage.
By Rebecca Shohet Published March 11, 2015
With ever-increasing advancements in technology, especially nw technological sound devices, more individuals, especially young adults, are expected to lose their hearing. Multiple organizations such as the World Health Organization (WHO) are trying to spread awareness and help lower these projections through multiple initiatives, but is it their right to do so?Which other governmental groups or nonprofit organizations, if any, should be held responsible for these initiatives?